Fig. 1From: Immune dysregulation associated with co-occurring germline CBL and SH2B3 variantsPedigree of the described Italian family. Figure summarizes clinical and genetic characteristics of the reported family. Patient I.2 is affected by Philadelphia positive chronic myeloid leukemia and is receiving treatment with Imatinib. The analysis of CBL variants performed on peripheral blood during clinical remission resulted negative. CML: chronic myelogenous leukemia; HSCT: hematopoietic stem cell transplantation; JMML: juvenile myelomonocytic leukemiaBack to article page